StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen puerto Rico Plan — Participant Contributions ($M) ($M)

Form 11-K Retirement and Savings Plan for Amgen Manufacturing Limited (Puerto Rico)

Latest, FY2025
20.0
Period ended Dec 31, 2025
Change on a year earlier
+4.1%
19.2 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Amgen Puerto Rico Plan — Participant Contributions ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan_pr_part_contrib

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.